Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Bioniz	Common Stock	Common Stock Bioniz	Additional Paid-in Capital	Additional Paid-in Capital Bioniz	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance at Dec. 31, 2021	$ 66,505		$ 2		$ 176,618		$ (138)	$ (109,977)
Balance, Shares at Dec. 31, 2021			29,455,668
Issuance of common stock		$ 22,542		$ 1		$ 22,541
Issuance of common stock, Shares				4,820,230
Vesting of restricted stock liability	18				18
Stock-based compensation expense	1,298				1,298
Other comprehensive income (loss)	(316)						(316)
Net loss	(37,417)							(37,417)
Balance at Mar. 31, 2022	52,630		$ 3		200,475		(454)	(147,394)
Balance, Shares at Mar. 31, 2022			34,275,898
Balance at Dec. 31, 2021	66,505		$ 2		176,618		(138)	(109,977)
Balance, Shares at Dec. 31, 2021			29,455,668
Other comprehensive income (loss)	(11)
Net loss	(51,546)
Balance at Jun. 30, 2022	40,267		$ 3		201,936		(149)	(161,523)
Balance, Shares at Jun. 30, 2022			34,352,084
Balance at Mar. 31, 2022	52,630		$ 3		200,475		(454)	(147,394)
Balance, Shares at Mar. 31, 2022			34,275,898
Issuance of common stock under employee stock purchase plan	141				141
Issuance of common stock under employee stock purchase plan, Shares			76,186
Vesting of restricted stock liability	18				18
Stock-based compensation expense	1,302				1,302
Other comprehensive income (loss)	305						305
Net loss	(14,129)							(14,129)
Balance at Jun. 30, 2022	40,267		$ 3		201,936		(149)	(161,523)
Balance, Shares at Jun. 30, 2022			34,352,084
Balance at Dec. 31, 2022	31,942		$ 3		204,268		76	(172,405)
Balance, Shares at Dec. 31, 2022			34,414,149
Stock-based compensation expense	1,038				1,038
Other comprehensive income (loss)	229						229
Net loss	(3,940)							(3,940)
Balance at Mar. 31, 2023	29,269		$ 3		205,306		305	(176,345)
Balance, Shares at Mar. 31, 2023			34,414,149
Balance at Dec. 31, 2022	31,942		$ 3		204,268		76	(172,405)
Balance, Shares at Dec. 31, 2022			34,414,149
Other comprehensive income (loss)	264
Net loss	(7,283)
Balance at Jun. 30, 2023	26,981		$ 3		206,326		340	(179,688)
Balance, Shares at Jun. 30, 2023			34,568,500
Balance at Mar. 31, 2023	29,269		$ 3		205,306		305	(176,345)
Balance, Shares at Mar. 31, 2023			34,414,149
Issuance of common stock under employee stock purchase plan	86				86
Issuance of common stock under employee stock purchase plan, Shares			154,351
Stock-based compensation expense	934				934
Other comprehensive income (loss)	35						35
Net loss	(3,343)							(3,343)
Balance at Jun. 30, 2023	$ 26,981		$ 3		$ 206,326		$ 340	$ (179,688)
Balance, Shares at Jun. 30, 2023			34,568,500